TWO-YEAR DATA COMPAIRING THE EFFICACY OF AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION IN TREATMENT NAIVE AND SWITCHOVER PATIENTS.

被引：0
作者：
McKenna, Michael [1 ]
Suleman, Javid [1 ]
Ting, Darren S. J. [1 ]
Pushpoth, Sreekumari [1 ]
Severn, Philip [1 ]
机构：
[1] James Cook Univ Hosp Ophthalmol, NHS, Middlesbrough, Teeside, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
422
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Changes in choroidal thickness after ranibizumab and aflibercept Therapy for treatment-naive wet age-related macular degeneration
    Kang, H. G.
    Kim, J. S.
    Lee, J. H.
    Kim, Y. I.
    Lee, S. H.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94
  • [22] THREE-YEAR OUTCOMES OF INTRAVITREAL AFLIBERCEPT INJECTION FOR TREATMENT NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Motoki, K.
    Yoshimi, N.
    Masayuki, O.
    Kyoko, F.
    Tomoyuki, C.
    Kazuki, N.
    Kanji, T.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E81 - E82
  • [23] Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naive Patients with Neovascular Age-related Macular Degeneration
    Eleftheriadou, Maria
    Gemenetzi, Maria K.
    Sivaprasad, Sobha
    Hykin, Philip G.
    Hamilton, Robin
    Tufail, Adnan
    Patel, Praveen J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Comparison of Intravitreal Aflibercept with Bevacizumab and Ranibizumab for the Treatment of Wet Age-related Macular Degeneration
    Shaikh, Adeel
    Miller, Daniel
    Petersen, Michael
    Foster, Robert
    Riemann, Christopher
    Sisk, Robert
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [25] COST-EFFECTIVENES OF AFLIBERCEPT IN THE TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION IN TURKEY
    Tunalioglu, A.
    Ozdemir, O.
    Eldem, B.
    Unlu, N.
    Alp, M. N.
    Saatci, A. O.
    Ozmert, E.
    Deger, C.
    Asan, S.
    Sumer, F.
    Parali, E.
    Ozel, M. O.
    Erdal, E.
    Sar, C.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A182 - A182
  • [26] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Two-Year Results
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L.
    [J]. OPHTHALMOLOGY, 2020, 127 (04) : S135 - S145
  • [27] Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
    Parvin, Parmis
    Zola, Marta
    Dirani, Ali
    Ambresin, Aude
    Mantel, Irmela
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (11) : 2127 - 2134
  • [28] Effect of aflibercept in patients with age-related macular degeneration
    Okuma, Hiroko
    Mimura, Tatsuya
    Goto, Mari
    Kamei, Yuko
    Yoshida, Maiko
    Kondo, Aki
    Matsubara, Masao
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2016, 36 (02) : 159 - 169
  • [29] Effect of aflibercept in patients with age-related macular degeneration
    Hiroko Okuma
    Tatsuya Mimura
    Mari Goto
    Yuko Kamei
    Maiko Yoshida
    Aki Kondo
    Masao Matsubara
    [J]. International Ophthalmology, 2016, 36 : 159 - 169
  • [30] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
12345